Sun Pharmaceutical Industries’ domestic sales were Rs 2,388 crore in April-June compared with Rs 2,364 crore in the previous quarter. Lupin’s domestic business fell 6% from the same quarter last year.
Coronavirus is making it tough to breathe, even for Indian pharmaceuticals
